Opus Genetics, Inc. Operating Income
Opus Genetics, Inc. (IRD) reported Operating Income of -$16.48 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- Opus Genetics, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$16.48M.
- Opus Genetics, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$14.36M.
- Opus Genetics, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$11.45M.
- Opus Genetics, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$8.31M.
- Opus Genetics, Inc. operating income (loss) for fiscal 2025 was -$38.60M.
- Opus Genetics, Inc. operating income (loss) for fiscal 2024 was -$62.07M.
- Opus Genetics, Inc. operating income (loss) for fiscal 2023 was -$10.56M, a 157.96% decline from fiscal 2022.
- Opus Genetics, Inc. operating income (loss) for fiscal 2022 was $18.23M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed | Operating Income (Loss) 132 month | Operating Income (Loss) 135 month | Operating Income (Loss) 138 month | Operating Income (Loss) 141 month | Operating Income (Loss) 144 month | Operating Income (Loss) 147 month | Operating Income (Loss) 150 month | Operating Income (Loss) 153 month | Operating Income (Loss) 156 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$16.48M 10-Q · filed 2026-08-06 | -$30.84M 10-Q · filed 2026-08-06 | -$42.30M derived: sum of 3 quarters · filed 2026-08-06 | -$50.61M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2026-03-31 | -$14.36M 10-Q · filed 2026-05-12 | -$25.82M derived: sum of 2 quarters · filed 2026-05-12 | -$34.13M derived: sum of 3 quarters · filed 2026-05-12 | -$43.03M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2025-12-31 | -$11.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$19.76M derived: sum of 2 quarters · filed 2026-03-12 | -$28.67M derived: sum of 3 quarters · filed 2026-08-06 | -$38.60M 10-K · filed 2026-03-12 | |||||||||||||
| 2025-09-30 | -$8.31M 10-Q · filed 2025-11-12 | -$17.22M derived: sum of 2 quarters · filed 2026-08-06 | -$27.15M 10-Q · filed 2025-11-12 | -$65.17M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2025-06-30 | -$8.91M 10-Q · filed 2026-08-06 | -$18.84M 10-Q · filed 2026-08-06 | -$56.86M derived: sum of 3 quarters · filed 2026-08-06 | -$64.87M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2025-03-31 | -$9.93M 10-Q · filed 2026-05-12 | -$47.96M derived: sum of 2 quarters · filed 2026-05-12 | -$55.97M derived: sum of 3 quarters · filed 2026-05-12 | -$64.30M derived: sum of 4 quarters · filed 2026-05-12 | |||||||||||||
| 2024-12-31 | -$38.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$46.04M derived: sum of 2 quarters · filed 2026-03-12 | -$54.37M derived: sum of 3 quarters · filed 2026-03-12 | -$62.07M 10-K · filed 2026-03-12 | |||||||||||||
| 2024-09-30 | -$8.01M 10-Q · filed 2025-11-12 | -$16.34M derived: sum of 2 quarters · filed 2025-11-12 | -$24.05M 10-Q · filed 2025-11-12 | -$29.47M derived: sum of 4 quarters · filed 2025-11-12 | |||||||||||||
| 2024-06-30 | -$8.33M 10-Q · filed 2025-08-13 | -$16.04M 10-Q · filed 2025-08-13 | -$21.46M derived: sum of 3 quarters · filed 2025-08-13 | -$15.08M derived: sum of 4 quarters · filed 2025-08-13 | |||||||||||||
| 2024-03-31 | -$7.71M 10-Q · filed 2025-05-15 | -$13.14M derived: sum of 2 quarters · filed 2025-05-15 | -$6.75M derived: sum of 3 quarters · filed 2025-05-15 | -$12.14M derived: sum of 4 quarters · filed 2025-05-15 | |||||||||||||
| 2023-12-31 | -$5.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $957.00K derived: sum of 2 quarters · filed 2025-03-31 | -$4.43M derived: sum of 3 quarters · filed 2025-03-31 | -$10.56M 10-K · filed 2025-03-31 | |||||||||||||
| 2023-09-30 | $6.39M 10-Q · filed 2024-11-12 | $997.00K derived: sum of 2 quarters · filed 2024-11-12 | -$5.13M 10-Q · filed 2024-11-12 | $29.08M derived: sum of 4 quarters · filed 2024-11-12 | |||||||||||||
| 2023-06-30 | -$5.39M 10-Q · filed 2024-08-13 | -$11.52M 10-Q · filed 2024-08-13 | $22.69M derived: sum of 3 quarters · filed 2024-08-13 | $18.15M derived: sum of 4 quarters · filed 2024-08-13 | |||||||||||||
| 2023-03-31 | -$6.13M 10-Q · filed 2024-05-10 | $28.08M derived: sum of 2 quarters · filed 2024-05-10 | $23.54M derived: sum of 3 quarters · filed 2024-05-10 | $18.60M derived: sum of 4 quarters · filed 2024-05-10 | |||||||||||||
| 2022-12-31 | $34.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $29.67M derived: sum of 2 quarters · filed 2024-03-08 | $24.73M derived: sum of 3 quarters · filed 2024-03-08 | $18.23M 10-K · filed 2024-03-08 | |||||||||||||
| 2022-09-30 | -$4.54M 10-Q · filed 2023-11-13 | -$9.48M derived: sum of 2 quarters · filed 2023-11-13 | -$15.98M 10-Q · filed 2023-11-13 | -$22.13M derived: sum of 4 quarters · filed 2023-11-13 | |||||||||||||
| 2022-06-30 | -$4.94M 10-Q · filed 2023-08-11 | -$11.45M 10-Q · filed 2023-08-11 | -$17.60M derived: sum of 3 quarters · filed 2023-08-11 | -$21.83M derived: sum of 4 quarters · filed 2023-08-11 | |||||||||||||
| 2022-03-31 | -$6.51M 10-Q · filed 2023-05-15 | -$12.66M derived: sum of 2 quarters · filed 2023-05-15 | -$16.89M derived: sum of 3 quarters · filed 2023-05-15 | -$24.03M derived: sum of 4 quarters · filed 2023-05-15 | |||||||||||||
| 2021-12-31 | -$6.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$10.38M derived: sum of 2 quarters · filed 2023-03-30 | -$17.52M derived: sum of 3 quarters · filed 2023-03-30 | -$22.70M 10-K · filed 2023-03-30 | |||||||||||||
| 2021-09-30 | -$4.23M 10-Q · filed 2022-11-04 | -$11.37M derived: sum of 2 quarters · filed 2022-11-04 | -$16.55M 10-Q · filed 2022-11-04 | -$30.58M derived: sum of 4 quarters · filed 2022-11-04 | |||||||||||||
| 2021-06-30 | -$7.14M 10-Q · filed 2022-08-12 | -$12.32M 10-Q · filed 2022-08-12 | -$26.35M derived: sum of 3 quarters · filed 2022-08-12 | -$28.29M derived: sum of 4 quarters · filed 2022-08-12 | |||||||||||||
| 2021-03-31 | -$5.19M 10-Q · filed 2022-05-13 | -$19.21M derived: sum of 2 quarters · filed 2022-05-13 | -$21.16M derived: sum of 3 quarters · filed 2022-05-13 | -$22.42M derived: sum of 4 quarters · filed 2022-05-13 | |||||||||||||
| 2020-12-31 | -$14.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$15.97M derived: sum of 2 quarters · filed 2022-03-24 | -$17.23M derived: sum of 3 quarters · filed 2022-03-24 | -$19.97M 10-K · filed 2022-03-24 | |||||||||||||
| 2020-09-30 | -$1.95M 10-Q · filed 2021-11-12 | -$1.51M 10-Q · filed 2020-10-29 | -$3.21M derived: sum of 2 quarters · filed 2021-11-12 | -$5.95M 10-Q · filed 2021-11-12 | -$4.42M 10-Q · filed 2020-10-29 | -$931.21K derived: sum of 4 quarters · filed 2021-11-12 | |||||||||||
| 2020-06-30 | -$1.26M 10-Q · filed 2021-08-12 | -$2.35M 10-Q · filed 2020-08-14 | -$4.00M 10-Q · filed 2021-08-12 | -$2.91M 10-Q · filed 2020-08-14 | $1.02M derived: sum of 3 quarters · filed 2021-08-12 | -$1.26M derived: sum of 4 quarters · filed 2021-08-12 | |||||||||||
| 2020-03-31 | -$2.73M 10-Q · filed 2021-05-07 | -$562.80K 10-Q · filed 2020-05-07 | $2.28M derived: sum of 2 quarters · filed 2021-05-07 | -$1.83K derived: sum of 3 quarters · filed 2021-05-07 | -$2.99M derived: sum of 4 quarters · filed 2021-05-07 | ||||||||||||
| 2019-12-31 | $5.01M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $2.73M derived: sum of 2 quarters · filed 2021-03-11 | -$255.25K derived: sum of 3 quarters · filed 2021-03-11 | -$4.19M 10-K · filed 2021-03-11 | -$11.22M 10-K · filed 2020-02-21 | ||||||||||||
| 2019-09-30 | -$2.28M 10-Q · filed 2020-10-29 | -$5.27M derived: sum of 2 quarters · filed 2020-10-29 | -$9.21M 10-Q · filed 2020-10-29 | -$14.17M derived: sum of 4 quarters · filed 2020-10-29 | |||||||||||||
| 2019-06-30 | -$2.99M 10-Q · filed 2020-08-14 | -$6.93M 10-Q · filed 2020-08-14 | -$11.89M derived: sum of 3 quarters · filed 2020-08-14 | -$16.58M derived: sum of 4 quarters · filed 2020-08-14 | |||||||||||||
| 2019-03-31 | -$3.94M 10-Q · filed 2020-05-07 | -$8.90M derived: sum of 2 quarters · filed 2020-05-07 | -$13.59M derived: sum of 3 quarters · filed 2020-05-07 | -$18.59M derived: sum of 4 quarters · filed 2020-05-07 | |||||||||||||
| 2018-12-31 | -$4.97M 10-K · filed 2019-03-07 | -$9.65M derived: sum of 2 quarters · filed 2019-11-06 | -$14.65M derived: sum of 3 quarters · filed 2019-11-06 | -$20.54M 10-K · filed 2020-02-21 | |||||||||||||
| 2018-09-30 | -$4.68M 10-Q · filed 2019-11-06 | -$9.69M derived: sum of 2 quarters · filed 2019-11-06 | -$15.57M 10-Q · filed 2019-11-06 | -$20.47M derived: sum of 4 quarters · filed 2019-11-06 | |||||||||||||
| 2018-06-30 | -$5.00M 10-Q · filed 2019-08-07 | -$10.89M 10-Q · filed 2019-08-07 | -$15.79M derived: sum of 3 quarters · filed 2019-08-07 | -$20.00M derived: sum of 4 quarters · filed 2019-08-07 | |||||||||||||
| 2018-03-31 | -$5.89M 10-Q · filed 2019-05-10 | -$10.78M derived: sum of 2 quarters · filed 2019-05-10 | -$15.00M derived: sum of 3 quarters · filed 2019-05-10 | -$19.29M derived: sum of 4 quarters · filed 2019-05-10 | |||||||||||||
| 2017-12-31 | -$4.90M 10-K · filed 2019-03-07 | -$9.12M derived: sum of 2 quarters · filed 2019-03-07 | -$13.40M derived: sum of 3 quarters · filed 2019-03-07 | -$17.35M 10-K · filed 2019-03-07 | |||||||||||||
| 2017-09-30 | -$4.22M 10-K · filed 2019-03-07 | -$8.50M derived: sum of 2 quarters · filed 2019-03-07 | -$12.46M 10-Q · filed 2018-11-02 | -$16.38M derived: sum of 4 quarters · filed 2019-03-07 | |||||||||||||
| 2017-06-30 | -$4.28M 10-K · filed 2019-03-07 | -$8.24M 10-Q · filed 2018-08-03 | -$12.16M derived: sum of 3 quarters · filed 2019-03-07 | -$15.87M derived: sum of 4 quarters · filed 2019-03-07 | |||||||||||||
| 2017-03-31 | -$3.95M 10-K · filed 2019-03-07 | -$7.87M derived: sum of 2 quarters · filed 2019-03-07 | -$11.59M derived: sum of 3 quarters · filed 2019-03-07 | -$15.50M derived: sum of 4 quarters · filed 2019-03-07 | |||||||||||||
| 2016-12-31 | -$3.92M 10-K · filed 2018-03-09 | -$7.64M derived: sum of 2 quarters · filed 2018-03-09 | -$11.55M derived: sum of 3 quarters · filed 2018-03-09 | -$16.41M 10-K · filed 2018-03-09 | |||||||||||||
| 2016-09-30 | -$3.72M 10-K · filed 2018-03-09 | -$7.63M derived: sum of 2 quarters · filed 2018-03-09 | -$12.49M 10-Q · filed 2017-11-03 | -$16.86M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||||||
| 2016-06-30 | -$3.91M 10-K · filed 2018-03-09 | -$8.78M 10-Q · filed 2017-08-04 | -$13.14M derived: sum of 3 quarters · filed 2018-03-09 | -$17.80M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||||||
| 2016-03-31 | -$4.86M 10-K · filed 2018-03-09 | -$9.23M derived: sum of 2 quarters · filed 2018-03-09 | -$13.89M derived: sum of 3 quarters · filed 2018-03-09 | -$18.71M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||||||
| 2015-12-31 | -$4.37M 10-K · filed 2017-02-24 | -$9.03M derived: sum of 2 quarters · filed 2017-02-24 | -$13.85M derived: sum of 3 quarters · filed 2017-02-24 | -$18.26M 10-K · filed 2018-03-09 | |||||||||||||
| 2015-09-30 | -$4.66M 10-K · filed 2017-02-24 | -$9.48M derived: sum of 2 quarters · filed 2017-02-24 | -$13.90M 10-Q · filed 2016-11-04 | -$17.75M derived: sum of 4 quarters · filed 2017-02-24 | |||||||||||||
| 2015-06-30 | -$4.82M 10-K · filed 2017-02-24 | -$9.24M 10-Q · filed 2016-08-05 | -$13.09M derived: sum of 3 quarters · filed 2017-02-24 | -$16.23M derived: sum of 4 quarters · filed 2017-02-24 | |||||||||||||
| 2015-03-31 | -$4.42M 10-K · filed 2017-02-24 | -$8.27M derived: sum of 2 quarters · filed 2017-02-24 | -$11.41M derived: sum of 3 quarters · filed 2017-02-24 | -$14.92M derived: sum of 4 quarters · filed 2017-02-24 | |||||||||||||
| 2014-12-31 | -$3.85M 10-K · filed 2016-03-14 | -$6.99M derived: sum of 2 quarters · filed 2016-03-14 | -$10.50M derived: sum of 3 quarters · filed 2016-03-14 | -$13.27M 10-K · filed 2017-02-24 | |||||||||||||
| 2014-09-30 | -$3.14M 10-K · filed 2016-03-14 | -$6.65M derived: sum of 2 quarters · filed 2016-03-14 | -$9.42M 10-Q · filed 2015-11-02 | -$11.75M derived: sum of 4 quarters · filed 2016-03-14 | |||||||||||||
| 2014-06-30 | -$3.51M 10-K · filed 2016-03-14 | -$6.28M 10-Q · filed 2015-08-07 | -$8.61M derived: sum of 3 quarters · filed 2016-03-14 | -$10.43M derived: sum of 4 quarters · filed 2016-03-14 | |||||||||||||
| 2014-03-31 | -$2.77M 10-K · filed 2016-03-14 | -$5.10M derived: sum of 2 quarters · filed 2016-03-14 | -$6.92M derived: sum of 3 quarters · filed 2016-03-14 | -$8.84M derived: sum of 4 quarters · filed 2016-03-14 | -$79.30M 10-Q · filed 2014-05-14 | ||||||||||||
| 2013-12-31 | -$2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | -$4.16M derived: sum of 2 quarters · filed 2016-03-14 | -$6.07M derived: sum of 3 quarters · filed 2016-03-14 | -$7.98M 10-K · filed 2016-03-14 | -$76.53M 10-K · filed 2014-03-21 | ||||||||||||
| 2013-09-30 | -$1.82M 10-Q · filed 2014-11-12 | -$3.74M derived: sum of 2 quarters · filed 2014-11-12 | -$5.65M 10-Q · filed 2014-11-12 | -$6.69M derived: sum of 4 quarters · filed 2014-11-12 | -$74.20M 10-Q · filed 2013-11-13 | ||||||||||||
| 2013-06-30 | -$1.91M 10-Q · filed 2014-08-13 | -$3.82M 10-Q · filed 2014-08-13 | -$4.87M derived: sum of 3 quarters · filed 2014-08-13 | -$6.67M derived: sum of 4 quarters · filed 2014-08-13 | -$72.38M 10-Q · filed 2013-08-12 | ||||||||||||
| 2013-03-31 | -$1.91M 10-Q · filed 2014-05-14 | -$2.96M derived: sum of 2 quarters · filed 2014-05-14 | -$4.76M derived: sum of 3 quarters · filed 2014-05-14 | -$6.60M derived: sum of 4 quarters · filed 2014-05-14 | -$70.46M 10-Q · filed 2013-05-09 | ||||||||||||
| 2012-12-31 | -$1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | -$2.85M derived: sum of 2 quarters · filed 2014-03-21 | -$4.70M derived: sum of 3 quarters · filed 2014-03-21 | -$6.58M 10-K · filed 2014-03-21 | -$68.55M 10-K · filed 2013-03-22 | ||||||||||||
| 2012-09-30 | -$1.80M 10-Q · filed 2013-11-13 | -$3.65M derived: sum of 2 quarters · filed 2013-11-13 | -$5.53M 10-Q · filed 2013-11-13 | -$7.94M derived: sum of 4 quarters · filed 2013-11-13 | -$67.51M 10-Q · filed 2012-11-08 | ||||||||||||
| 2012-06-30 | -$1.85M 10-Q · filed 2013-08-12 | -$3.73M 10-Q · filed 2013-08-12 | -$6.14M derived: sum of 3 quarters · filed 2013-08-12 | -$9.49M derived: sum of 4 quarters · filed 2013-08-12 | -$65.71M 10-Q · filed 2012-08-08 | ||||||||||||
| 2012-03-31 | -$1.88M 10-Q · filed 2013-05-09 | -$4.29M derived: sum of 2 quarters · filed 2013-05-09 | -$7.64M derived: sum of 3 quarters · filed 2013-05-09 | -$14.10M derived: sum of 4 quarters · filed 2013-05-09 | -$63.86M 10-Q · filed 2012-05-09 | ||||||||||||
| 2011-12-31 | -$2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | -$5.76M derived: sum of 2 quarters · filed 2013-03-22 | -$12.22M derived: sum of 3 quarters · filed 2013-03-22 | -$16.13M 10-K · filed 2013-03-22 | |||||||||||||
| 2011-09-30 | -$3.36M 10-Q · filed 2012-11-08 | -$9.81M derived: sum of 2 quarters · filed 2012-11-08 | -$13.73M 10-Q · filed 2012-11-08 | -$16.88M derived: sum of 4 quarters · filed 2012-11-08 | |||||||||||||
| 2011-06-30 | -$6.46M 10-Q · filed 2012-08-08 | -$10.37M 10-Q · filed 2012-08-08 | -$13.53M derived: sum of 3 quarters · filed 2012-08-08 | -$15.90M derived: sum of 4 quarters · filed 2012-08-08 | |||||||||||||
| 2011-03-31 | -$3.91M 10-Q · filed 2012-05-09 | -$7.07M derived: sum of 2 quarters · filed 2012-05-09 | -$9.44M derived: sum of 3 quarters · filed 2012-05-09 | -$12.63M derived: sum of 4 quarters · filed 2012-05-09 | |||||||||||||
| 2010-12-31 | -$3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16 | -$5.52M derived: sum of 2 quarters · filed 2012-03-16 | -$8.71M derived: sum of 3 quarters · filed 2012-03-16 | -$10.31M 10-K · filed 2012-03-16 | |||||||||||||
| 2010-09-30 | -$2.37M 10-Q · filed 2011-11-09 | -$5.56M derived: sum of 2 quarters · filed 2011-11-09 | -$7.15M 10-Q · filed 2011-11-09 | ||||||||||||||
| 2010-06-30 | -$3.19M 10-Q · filed 2011-08-09 | -$4.78M 10-Q · filed 2011-08-09 | |||||||||||||||
| 2009-12-31 | -$6.47M 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |